What's New
Last Posted: Sep 11, 2020
- Evaluation of CDC's Hemophilia Surveillance Program - Universal Data Collection (1998-2011) and Community Counts (2011-2019), United States.
Schieve Laura A et al. Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) 2020 Sep (5) 1-18 - Newborn Screening Practices and Alpha-Thalassemia Detection — United States, 2016
MA Bender et al, MMWR, September 11, 2020 - BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A.
Konkle Barbara A et al. The New England journal of medicine 2020 Sep (11) 1018-1027 - Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action
NASEM event, September 10, 2020 - When Actions Speak Louder Than Words - Racism and Sickle Cell Disease.
Power-Hays Alexandra et al. The New England journal of medicine 2020 Sep - An Innovative Multilevel Test for Hemoglobinopathies: TGA/Chemometrics Simultaneously Identifies and Classifies Sickle Cell Disease From Thalassemia.
Risoluti Roberta et al. Frontiers in molecular biosciences 2020 7141 - Evaluation of a screening program for iron overload and HFE mutations in 50,493 blood donors.
Eckerström Carl et al. Annals of hematology 2020 Aug - [Analysis of gene mutations and clinic features in 108 patients with myeloproliferative neoplasm].
Tan Y X et al. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2020 Jul 41(7) 576-582 - Appropriate thresholds for accurate screening for β-thalassemias in the newborn period: results from a French center for newborn screening.
Allaf Bichr et al. Clinical chemistry and laboratory medicine 2020 Aug - Fetal Hemoglobin in Sickle Cell Anemia.
Steinberg Martin H et al. Blood 2020 Aug - Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 36-year period
Jakó János et al. Orvosi hetilap 2020 161(34) 1400-1413 - Public Health Webinar Series on Blood Disorders: Update on COVID-19 and Thrombosis Risk
September 17, 2020 - 2:00-3:00 PM ET - Evaluation of demographic, pathologic, and clinical characteristics and overall survival of patients with colon cancer in Northern Iran (Mazandaran Province) during 2012-2019.
Rahimi Elahe et al. Gastroenterology and hepatology from bed to bench 2020 13(3) 209-218 - Extremely high birth prevalence of sickle cell disease in rural Tanzania.
Eastburg Luke et al. Pediatric blood & cancer 2020 Aug e28620 - Prevalence of FVIII Inhibitors Among Children with Hemophilia A: Experience at the Jordanian Royal Medical Services.
Oudat Raida et al. Medical archives (Sarajevo, Bosnia and Herzegovina) 2020 Jun 74(3) 187-190 - Beliefs and Values About Gene Therapy and In-Utero Gene Editing in Patients with Hemophilia and Their Relatives.
Vasquez-Loarte Tania C et al. The patient 2020 Aug - Gene therapy for hemophilia: anticipating the unexpected.
Pierce Glenn F et al. Blood advances 2020 Aug 4(15) 3788 - Influence of gender norms in relation to child's quality of care: follow-up of families of children with SCD identified through NBS in Tanzania.
Bukini Daima et al. Journal of community genetics 2020 Aug - CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs.
Morishige Satoshi et al. International journal of hematology 2020 Feb 111(2) 225-233 - How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease.
Leebeek Frank W G et al. Blood 2020 Aug
.png)
No hay comentarios:
Publicar un comentario